Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA)

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05397509

Acronym

OLIFTEA

Enrollment

Registered

2022-05-31

Start date

2022-04-29

Completion date

2022-06-30

Last updated

2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose

Brief summary

This study tests the effect of Olive Tea Ingestion in ameliorating glycemic response after a high-glycemic meal

Detailed description

This study is a double-blinded, randomized, placebo-controlled clinical trial with cross-over design.

Interventions

OTHEROlive leaf tea

250 mL of Olive leaf tea and a high-glycemic breakfast

OTHERPlacebo tea

250 mL of placebo tea and a high-glycemic breakfast

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

olive leaf tea and placebo tea were offered in a opaque mug

Intervention model description

Each participant will test one beverage on the first visit and the other one on the second visit. A wash-out period of two weeks will be done. Allocation of the first beverage to each participant is made by randomization.

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

Exclusion criteria

* currently taking drugs interfering with glucose regulation

Design outcomes

Primary

Measure	Time frame	Description
Blood glucose	120 minutes	Area under the curve

Countries

Portugal

Contacts

Primary ContactManuela Meireles, PhD

manuela.meireles@ipb.pt273330984

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026